269 related articles for article (PubMed ID: 23519972)
1. Association of vitamin D and multiple sclerosis in India.
Pandit L; Ramagopalan SV; Malli C; D'Cunha A; Kunder R; Shetty R
Mult Scler; 2013 Oct; 19(12):1592-6. PubMed ID: 23519972
[TBL] [Abstract][Full Text] [Related]
2. Sunlight is associated with decreased multiple sclerosis risk: no interaction with human leukocyte antigen-DRB1*15.
Bäärnhielm M; Hedström AK; Kockum I; Sundqvist E; Gustafsson SA; Hillert J; Olsson T; Alfredsson L
Eur J Neurol; 2012 Jul; 19(7):955-62. PubMed ID: 22289117
[TBL] [Abstract][Full Text] [Related]
3. 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis.
Soilu-Hänninen M; Airas L; Mononen I; Heikkilä A; Viljanen M; Hänninen A
Mult Scler; 2005 Jun; 11(3):266-71. PubMed ID: 15957505
[TBL] [Abstract][Full Text] [Related]
4. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis.
Simpson S; Taylor B; Blizzard L; Ponsonby AL; Pittas F; Tremlett H; Dwyer T; Gies P; van der Mei I
Ann Neurol; 2010 Aug; 68(2):193-203. PubMed ID: 20695012
[TBL] [Abstract][Full Text] [Related]
5. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis.
Soilu-Hänninen M; Laaksonen M; Laitinen I; Erälinna JP; Lilius EM; Mononen I
J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):152-7. PubMed ID: 17578859
[TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype.
Lonergan R; Kinsella K; Fitzpatrick P; Brady J; Murray B; Dunne C; Hagan R; Duggan M; Jordan S; McKenna M; Hutchinson M; Tubridy N
J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):317-22. PubMed ID: 21248317
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians.
Orton SM; Ramagopalan SV; Para AE; Lincoln MR; Handunnetthi L; Chao MJ; Morahan J; Morrison KM; Sadovnick AD; Ebers GC
J Neurol Sci; 2011 Jun; 305(1-2):116-20. PubMed ID: 21440908
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory effects of Vitamin D in multiple sclerosis.
Correale J; Ysrraelit MC; Gaitán MI
Brain; 2009 May; 132(Pt 5):1146-60. PubMed ID: 19321461
[TBL] [Abstract][Full Text] [Related]
9. Low sun exposure increases multiple sclerosis risk both directly and indirectly.
Hedström AK; Olsson T; Kockum I; Hillert J; Alfredsson L
J Neurol; 2020 Apr; 267(4):1045-1052. PubMed ID: 31844981
[TBL] [Abstract][Full Text] [Related]
10. Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis.
Brola W; Sobolewski P; Szczuchniak W; Góral A; Fudala M; Przybylski W; Opara J
Eur J Clin Nutr; 2016 Sep; 70(9):995-9. PubMed ID: 27026420
[TBL] [Abstract][Full Text] [Related]
11. Sun exposure and vitamin D are independent risk factors for CNS demyelination.
Lucas RM; Ponsonby AL; Dear K; Valery PC; Pender MP; Taylor BV; Kilpatrick TJ; Dwyer T; Coulthard A; Chapman C; van der Mei I; Williams D; McMichael AJ
Neurology; 2011 Feb; 76(6):540-8. PubMed ID: 21300969
[TBL] [Abstract][Full Text] [Related]
12. Determinants of vitamin D status in adult Crohn's disease patients, with particular emphasis on supplemental vitamin D use.
Gilman J; Shanahan F; Cashman KD
Eur J Clin Nutr; 2006 Jul; 60(7):889-96. PubMed ID: 16493452
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment.
Løken-Amsrud KI; Holmøy T; Bakke SJ; Beiske AG; Bjerve KS; Bjørnarå BT; Hovdal H; Lilleås F; Midgard R; Pedersen T; Benth JS; Sandvik L; Torkildsen O; Wergeland S; Myhr KM
Neurology; 2012 Jul; 79(3):267-73. PubMed ID: 22700809
[TBL] [Abstract][Full Text] [Related]
14. Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS.
Stewart N; Simpson S; van der Mei I; Ponsonby AL; Blizzard L; Dwyer T; Pittas F; Eyles D; Ko P; Taylor BV
Neurology; 2012 Jul; 79(3):254-60. PubMed ID: 22700816
[TBL] [Abstract][Full Text] [Related]
15. Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
Fitzgerald KC; Munger KL; Köchert K; Arnason BG; Comi G; Cook S; Goodin DS; Filippi M; Hartung HP; Jeffery DR; O'Connor P; Suarez G; Sandbrink R; Kappos L; Pohl C; Ascherio A
JAMA Neurol; 2015 Dec; 72(12):1458-65. PubMed ID: 26458124
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D and body mass index in Egyptian multiple sclerosis patients.
Zamzam D; Foad M; Swelam M; AbdelHafez M; AbdelNasser A; Mahmoud R; Aref H; Zakaria M
Mult Scler Relat Disord; 2019 Feb; 28():313-316. PubMed ID: 30823981
[TBL] [Abstract][Full Text] [Related]
17. Are the current Australian sun exposure guidelines effective in maintaining adequate levels of 25-hydroxyvitamin D?
Kimlin M; Sun J; Sinclair C; Heward S; Hill J; Dunstone K; Brodie A
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt B):264-70. PubMed ID: 25797374
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia.
van der Mei IA; Ponsonby AL; Dwyer T; Blizzard L; Taylor BV; Kilpatrick T; Butzkueven H; McMichael AJ
J Neurol; 2007 May; 254(5):581-90. PubMed ID: 17426912
[TBL] [Abstract][Full Text] [Related]
19. Effects of sun exposure on 25(OH) vitamin D concentration in urban and rural women in Malaysia.
Nurbazlin M; Chee WS; Rokiah P; Tan AT; Chew YY; Nusaibah AR; Chan SP
Asia Pac J Clin Nutr; 2013; 22(3):391-9. PubMed ID: 23945409
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D and multiple sclerosis.
Ascherio A; Munger KL; Simon KC
Lancet Neurol; 2010 Jun; 9(6):599-612. PubMed ID: 20494325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
